FDA accepts Takeda's oveporexton NDA with priority review for narcolepsy type 1

Eli Lilly signs definitive agreement to acquire Orna Therapeutics

CiteAb launches new scientific image search tool and improved reagent search engine

Innocan Pharma reports findings from clinical study of LPT-CBD in dogs

Lunai Bioworks starts new oncology collaboration with clinical-stage partner

BioArctic and Eisai secure Priority Review in China for subcutaneous Leqembi

Sanofi's rilzabrutinib receives FDA breakthrough and Japan orphan designations for rare anaemia

Kelun-Biotech reports fourth indication for sac-TMT approved by NMPA in HR+/HER2- breast cancer

Delonix Bioworks gets IND clearance for DX-104 in China

Innovent Biologics collaborates with Eli Lilly to develop new oncology and immunology treatments

Ascentage Pharma receives China IND clearance for BTK degrader APG‑3288

BioArctic reports higher royalties as Leqembi sales reach JPY20.7bn in Q4 2025

K36 Therapeutics completes first patient cohort dosing for Phase 1 trial of KTX-2001

Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban

Cizzle Biotechnology secures Canadian patent for lung cancer biomarker test